RQ 06
Alternative Names: RQ-06Latest Information Update: 17 Nov 2023
At a glance
- Originator Red Queen Therapeutics
- Class Antivirals; Peptides
- Mechanism of Action Viral fusion protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Parainfluenza virus infections
Most Recent Events
- 12 Oct 2023 Early research in Parainfluenza virus infections in USA (Intranasal) (Queen Therapeutics pipeline, October 2023)